Want to see IN:LOTUSEYE full AI Analyst Report?
LOTUSEYE Stock Chart & Stats
₹118.10
-₹0.92(-1.30%)
At close: 4:00 PM EST
₹118.10
-₹0.92(-1.30%)
Day’s Range― - ―
52-Week Range₹75.34 - ₹153.00
Previous CloseN/A
Volume15.88K
Average Volume (3M)2.23K
Market Cap
₹2.41B
Enterprise Value₹2.50K
Total Cash (Recent Filing)₹38.27M
Total Debt (Recent Filing)₹158.34M
Price to Earnings (P/E)1440.3
Beta0.85
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding20,796,330
10 Day Avg. Volume4,541
30 Day Avg. Volume2,230
Financial Highlights & Ratios
PEG Ratio-27.83
Price to Book (P/B)3.28
Price to Sales (P/S)3.68
P/FCF Ratio-18.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Specialist Ophthalmology BusinessA pure-play ophthalmology provider with hospitals and clinics concentrates clinical expertise, referral networks and procedure-led revenue. That specialization supports repeatable demand for consultations, diagnostics, surgeries and ancillaries, creating durable service cash flows and operational focus over months.
Equity-backed Balance SheetThe company has a sizeable equity base relative to debt, providing a capital cushion to absorb shocks and fund operations or measured expansion. This equity support gives management room to address short-term cash needs without immediate solvency pressure, a durable financial strength factor.
Positive Operating Cash FlowOperating cash flow remained positive, indicating the core eye-care services generate cash even as volumes or pricing fluctuate. Sustained OCF underpins working capital needs and operational continuity, supporting medium-term service delivery and potential targeted reinvestment despite weaker free cash flow.
Bears Say
Deep Negative Free Cash FlowA large negative free cash flow indicates capital spending and/or working-capital demands far exceed internally generated cash. Over a 2–6 month horizon this raises funding risk and likely requires external financing or cash management actions, constraining strategic flexibility and increasing refinancing exposure.
Rising LeverageLeverage rising rapidly from a low base reduces financial headroom; higher debt raises interest and covenant risk. Combined with weakened earnings, increased leverage meaningfully narrows the firm's ability to absorb demand shocks or fund investments without additional external capital over the medium term.
Margin DeteriorationSharp margin erosion—negative operating margin and near-zero net margin—signals weakening operating leverage and cost pressure. Persistently thin margins undermine return on capital and the firm's ability to convert revenue into sustainable profits, making recovery and de-leveraging more difficult over coming months.
Lotus Eye Hospital And Institute Ltd News
LOTUSEYE FAQ
What was Lotus Eye Hospital And Institute Ltd’s price range in the past 12 months?
Lotus Eye Hospital And Institute Ltd lowest stock price was ₹75.34 and its highest was ₹153.00 in the past 12 months.
What is Lotus Eye Hospital And Institute Ltd’s market cap?
Lotus Eye Hospital And Institute Ltd’s market cap is ₹2.41B.
When is Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date?
Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date is Nov 17, 2026 which is in 93 days.
How were Lotus Eye Hospital And Institute Ltd’s earnings last quarter?
Lotus Eye Hospital And Institute Ltd released its earnings results on Aug 10, 2026. The company reported ₹0.295 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.295.
Is Lotus Eye Hospital And Institute Ltd overvalued?
According to Wall Street analysts Lotus Eye Hospital And Institute Ltd’s price is currently Overvalued.
Does Lotus Eye Hospital And Institute Ltd pay dividends?
Lotus Eye Hospital And Institute Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Lotus Eye Hospital And Institute Ltd dividends here
What is Lotus Eye Hospital And Institute Ltd’s EPS estimate?
Lotus Eye Hospital And Institute Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Eye Hospital And Institute Ltd have?
Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding.
What happened to Lotus Eye Hospital And Institute Ltd’s price movement after its last earnings report?
Lotus Eye Hospital And Institute Ltd reported an EPS of ₹0.295 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.171%.
Which hedge fund is a major shareholder of Lotus Eye Hospital And Institute Ltd?
Currently, no hedge funds are holding shares in IN:LOTUSEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lotus Eye Hospital And Institute Ltd
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―